Jaguar Health (JAGX) Exchange Rate Effect (2022 - 2026)
Jaguar Health (JAGX) posted quarterly Exchange Rate Effect of -$458000.0 for Q1 2026, down 74.81% year-over-year from -$1.8 million in Q1 2025, and down 250.16% quarter-over-quarter from $305000.0 in Q4 2025.
Jaguar Health (JAGX) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Exchange Rate Effect for 5 consecutive years, with -$458000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 74.81% year-over-year to -$458000.0; the TTM figure through Mar 2026 stood at -$309000.0 (up 46.35% YoY), while the FY2025 annual figure was -$113000.0, down 109.26% from the prior year.
- Exchange Rate Effect fell to -$458000.0 in Q1 2026 per JAGX's latest filing, from $305000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $305000.0 in Q4 2025 and bottomed at -$458000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged -$34882.4 across 5 years, with a median of -$22000.0 in 2025.
- On a YoY basis, Exchange Rate Effect climbed as much as 644.64% in 2025 and fell as far as 1278.95% in 2025.
- Jaguar Health's Exchange Rate Effect stood at $54000.0 in 2022, then jumped by 201.85% to $163000.0 in 2023, then slumped by 134.36% to -$56000.0 in 2024, then surged by 644.64% to $305000.0 in 2025, then plunged by 250.16% to -$458000.0 in 2026.
- Business Quant data shows JAGX's Exchange Rate Effect at -$458000.0 in Q1 2026, $305000.0 in Q4 2025, and -$134000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Jaguar Health | 448,683.98 | -9.62 Mn | 19.11 Mn | -458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -458,000.00 |
| Mar 31, 2026 | -458,000.00 |
| Dec 31, 2025 | 305,000.00 |
| Dec 31, 2025 | 305,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -262,000.00 |
| Mar 31, 2025 | -262,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Dec 31, 2023 | 163,000.00 |